Aqr Capital Management LLC Rvl Pharmaceuticals PLC Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.8 - $3.78 $45,138 - $60,937	-16,121 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.26 - $4.84 $309 - $459	95 Added 0.59%	16,121 $53,000
Q4 2020 Feb 16, 2021	SELL	$4.12 - $6.29 $223,201 - $340,760	-54,175 Reduced 77.17%	16,026 $66,000
Q3 2020 Nov 16, 2020	SELL	$4.82 - $8.77 $277,574 - $505,046	-57,588 Reduced 45.06%	70,201 $380,000
Q2 2020 Aug 17, 2020	BUY	$2.83 - $6.99 $49,077 - $121,220	17,342 Added 15.7%	127,789 $860,000
Q1 2020 May 15, 2020	BUY	$3.18 - $7.0 $351,221 - $773,129	110,447 New	110,447 $351,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.